Merck
HomeWebinarsUpcoming USP <665> - Level of Characterization of Single-Use Systems Today and Tomorrow

Upcoming USP <665> - Level of Characterization of Single-Use Systems Today and Tomorrow



WEBINAR

Single-use plastic systems are being utilized more frequently, especially for COVID-19 vaccine manufacturing. However, issues regarding the standardization of quality information limit implementation efficiencies. One of the challenges is the evaluation of leachables derived from a variety of different plastic components in a timely manner.

Since the USP <665> highlights a risk assessment approach with no typical pass/fail limit, we discuss approaches to decision-making based on the extractables data package. In addition, we highlight legacy testing requirements which may not be necessary once USP <665> is implemented.

In this webinar, we will discuss:

  • Regulatory expectations of extractables and leachables assessment today and tomorrow
  • The right criteria that need to be assessed to select the type and quality of plastic materials for use in biopharmaceutical manufacturing

Speaker

Simone Biel, Ph.D.

Simone Biel, Ph.D.

Merck

Senior Regulatory Consultant

Simone Biel provides regulatory and scientific expertise to our customers and internal stakeholders globally with a focus on single-use technology. Over the years, Simone has supported biopharmaceutical drug manufacturers’ implementation of single-use technology in their manufacturing process. With her deep understanding of single-use technology market needs and industry trends, she is the subject matter expert to ensure that product performance meets quality and regulatory requirements. Simone holds a Ph.D. from the University of Frankfurt in microbiology.

Webinar Information

Pharma and biopharma manufacturing

  • mRNA
  • Duration:1hr

  • Language:English

  • Presented:Thu, July 15, 2021

    Watch Now